Source: Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tafur, I. Cherrez-Ojeda, R. Mantilla, T. Guerrero, I. Mendoza, O. Arroba, G. Jordan (Guayaquil, Ecuador). CA-125 index and non small cell lung cancer: case report. Eur Respir J 2006; 28: Suppl. 50, 595

Member's Comments

No comment yet.

Related content which might interest you: Non small cell lung cancer: options and outcome of treatment beyond second line Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Are there potential characteristical markers in bronquial fluid for diagnosis of small cell lung cancer (SCLC)? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Leukemoid reaction in large cell lung cancer a case report Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 First report of a very rare complication in a case of nonsmall cell lung carcinoma Source: Breathe, 17 (4) 210107; 10.1183/20734735.0107-2021 Year: 2021 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 The importance of Ki-67 proliferation index in small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Advanced non small cell lung cancer: an approach fit for the twenties Source: Virtual Congress 2020 – Lung cancer grand round Year: 2020 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 Giant non small cell lung cancer – diagnosis and treatment Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008 Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 136-142 Year: 2011 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005